当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:71.08亿  总市值:71.08亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金747,214,773.763,113,315,039.952,408,731,310.21,624,749,777.68
  收到其他与经营活动有关的现金79,887,323.52254,782,413.3206,417,695.22107,610,357.53
  经营活动现金流入小计827,102,097.283,368,097,453.252,615,149,005.421,732,360,135.21
  购买商品、接受劳务支付的现金128,028,012.25803,042,751.9576,240,178.76398,995,042.23
  支付给职工以及为职工支付的现金102,980,785.59414,983,189.84317,273,900.22208,043,744.99
  支付的各项税费81,373,693.95334,185,410.32231,061,331.98158,283,398.49
  支付其他与经营活动有关的现金322,182,627.751,349,511,518.69895,693,453.15613,682,062.06
  经营活动现金流出小计634,565,119.542,901,722,870.752,020,268,864.111,379,004,247.77
  经营活动产生的现金流量净额192,536,977.74466,374,582.5594,880,141.31353,355,887.44
二、投资活动产生的现金流量:
  取得投资收益收到的现金28,109,094.9153,115,957.56119,739,821.0849,601,318.79
  处置固定资产、无形资产和其他长期资产收回的现金净额87,7003,355,581.581,941,0001,888,500
  收到的其他与投资活动有关的现金1,227,534,016.141,359,435,780.13,823,510,038.552,481,747,750.27
  投资活动现金流入小计1,255,730,811.041,515,907,319.243,945,190,859.632,533,237,569.06
  购建固定资产、无形资产和其他长期资产支付的现金12,706,277.8764,762,582.2782,066,364.7656,315,581.84
  支付其他与投资活动有关的现金1,790,200,0001,624,965,281.754,774,160,986.583,140,816,300.47
  投资活动现金流出小计1,802,906,277.871,689,727,864.024,856,227,351.343,197,131,882.31
  投资活动产生的现金流量净额-547,175,466.83-173,820,544.78-911,036,491.71-663,894,313.25
三、筹资活动产生的现金流量:
  取得借款收到的现金-15,344,80015,344,80015,344,800
  收到其他与筹资活动有关的现金-12,083,833.11--
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-27,428,633.1115,344,80015,344,800
  偿还债务支付的现金2,107,102.6570,807,780.1868,672,815.1567,470,150
  分配股利、利润或偿付利息支付的现金75,847.66185,162,801.43101,953,700.22101,857,965.19
  其中:子公司支付给少数股东的股利、利润-2,240,000--
  支付其他与筹资活动有关的现金-3,418,179.86867,141.34867,141.34
  筹资活动现金流出小计2,182,950.31259,388,761.47171,493,656.71170,195,256.53
  筹资活动产生的现金流量净额-2,182,950.31-231,960,128.36-156,148,856.71-154,850,456.53
四、汇率变动对现金及现金等价物的影响-1,416,275.05-793,399.29-713,875.76-243,672.26
五、现金及现金等价物净增加额-358,237,714.4559,800,510.07-473,019,082.87-465,632,554.6
  加:期初现金及现金等价物余额1,212,075,732.871,120,473,303.891,120,473,303.891,120,473,303.89
  期末现金及现金等价物余额853,838,018.421,180,273,813.96647,454,221.02654,840,749.29
补充资料:
  净利润-425,618,864.59-231,288,231.71
  资产减值准备-10,186,190.21-44,149,228.19
  固定资产和投资性房地产折旧-190,068,914.4-86,657,238.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-190,068,914.4-86,657,238.64
  无形资产摊销-9,025,039.11-4,675,759.69
  长期待摊费用摊销-471,157.21-231,789.41
  处置固定资产、无形资产和其他长期资产的损失-707,422.32--419,694.25
  固定资产报废损失-664,130.83-0
  公允价值变动损失--39,679,633.48--20,859,960.15
  财务费用-2,128,986.49-1,267,083.45
  投资损失--123,468,458.42--34,665,215.33
  递延所得税-6,337,254.55-7,592,436.57
  其中:递延所得税资产减少--923,081.54-6,410,210.39
    递延所得税负债增加-7,260,336.09-1,182,226.18
  存货的减少-178,690,374.61-31,813,609.43
  经营性应收项目的减少--102,236,759.86--28,004,246.65
  经营性应付项目的增加--143,995,589.11--8,252,046.22
  其他--9,342,430.2-24,479,166.96
  现金的期末余额-1,180,273,813.96-654,840,749.29
  减:现金的期初余额-1,120,473,303.89-1,120,473,303.89
  现金及现金等价物的净增加额-59,800,510.07--465,632,554.6
公告日期2026-04-292026-04-032025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑